We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.
- Authors
Yang, Zhenyu; Bu, Chibin; Yuan, Wei; Shen, Zhaohua; Quan, Yongsheng; Wu, Shuai; Zhu, Changxin; Wang, Xiaoyan
- Abstract
<bold>Background and Aims: </bold>Crohn's disease (CD) is a chronic inflammatory bowel disorder associated with intestinal dysbiosis. This study aimed to determine the efficacy and safety of different methods of fecal microbiota transplantation (FMT), a potential therapy for CD.<bold>Methods: </bold>Patients with CD were randomized to receive FMT by gastroscopy or colonoscopy; a second transplantation was performed 1 week later. Patients were assessed by clinical evaluation and serum testing (at weeks 1, 2, 4, 6, and 8) and endoscopy (8 weeks after transplantation). Fecal DNA was extracted and analyzed using the Illuminal sequencing platform.<bold>Results: </bold>Of the 27 patients included in the study, clinical remission was achieved in 18 (66.7%); no significant difference was seen between the two methods. 76.9% of gastroscopy group patients and 64.3% of colonoscopy group patients experienced mild adverse events during or shortly after treatment. Microbiota diversity analyses showed that, in comparison with the donors, patients had lower operational taxonomic units (OTU; 117 vs. 258, p < 0.05) and Shannon diversity index (2.05 vs. 3.46, p < 0.05). The CD patients showed a significant increase in OTU and Shannon diversity index 2 weeks after FMT. In comparison with the donors, CD patients had lower levels of Bacteroides, Eubacterium, faecalibacterium, and Roseburia, and higher levels of Clostridium, Cronobacter, Fusobacterium, and Streptococcus.<bold>Conclusions: </bold>FMT was seen to be safe and effective in this cohort of patients with CD. No significant differences in clinical remission rate and adverse events were seen between the gastroscopy and colonoscopy groups. FMT was seen to increase the species richness in CD patients.
- Subjects
CHINA; CROHN'S disease; FECAL microbiota transplantation; SMALL intestine; COLON (Anatomy); DISEASE remission; SPECIES diversity; CROHN'S disease diagnosis; COLON microbiology; RESEARCH; COLONOSCOPY; TIME; RESEARCH methodology; EVALUATION research; MEDICAL cooperation; TREATMENT effectiveness; COMPARATIVE studies; BLIND experiment; GASTROSCOPY; LONGITUDINAL method; DEGENERATION (Pathology)
- Publication
Digestive Diseases & Sciences, 2020, Vol 65, Issue 1, p150
- ISSN
0163-2116
- Publication type
journal article
- DOI
10.1007/s10620-019-05751-y